The Diagnostic Imaging AI (artificial intelligence) focus page provides information, videos, podcasts, and the latest news about product developments, trial results, screening guidelines, and protocol guidance that touch on the development and use of AI across the healthcare continuum.
September 28th 2023
The MAGNETOM Viato.Mobile may facilitate improved access to MRI capabilities for patients with serious health conditions who lack geographic proximity to centers with advanced imaging.
September 22nd 2023
FDA Clears AI Software for CT Detection and Triage of Obstructive Hydrocephalus
September 13th 2023Indicated for the triage and notification of obstructive hydrocephalus on non-contrast brain computed tomography (CT), the artificial intelligence (AI)-enabled software is reportedly the first radiology triage modality to obtain the Food and Drug Administration’s (FDA) Breakthrough Device Designation.
Large Mammography Study Suggests AI is Equivalent to Radiologists for Double Reading of Exams
September 11th 2023In a prospective study of over 55,000 women who had screening mammography, researchers found that double-reading by a radiologist and artificial intelligence (AI) was non-inferior to double-reading by two radiologists in detecting breast cancer.
Can AI Match Radiologist Assessment of Screening Mammography Exams?
September 5th 2023In separate test sets that included challenging mammography cases, researchers found that artificial intelligence (AI) demonstrated similar sensitivity and specificity for detecting breast cancer in comparison to assessments from over 500 clinicians.
Viz.ai Gets FDA Nod for Hypertrophic Cardiomyopathy Module
August 16th 2023The De Novo approval for Viz HCM, which assesses electrocardiograms with artificial intelligence (AI) to identify possible cases of hypertrophic cardiomyopathy (HCM), is the 12th FDA clearance of algorithms on the Viz.ai Platform.
CMS Approves NTAP Reimbursement for AI-Powered EchoGo Heart Failure System
August 3rd 2023In what may represent the first CMS approval of a new technology add-on payment (NTAP) for an artificial intelligence (AI)-based heart failure detection platform, use of the EchoGo Heart Failure system will be eligible for up to $1,023.75 in NTAP reimbursement per acute hospital in-patient stay as of October 1, 2023.
Large Mammography Study Shows Significant Benefits with AI-Aided Screening
August 1st 2023Reportedly the first randomized trial to examine the impact of artificial intelligence (AI) on screening mammography, researchers found AI-aided screening led to a 20 percent increase in breast cancer detection and a 44.3 percent decrease in mammography screening workload.
Researchers Note Lack of Benefit with AI in Women with Dense Breasts
July 28th 2023In a study of over 1.300 women with dense breasts, the combination of mammography and ultrasound had a recall rate of 11.7 percent, a specificity rate of 89.1 percent and an accuracy rate of 89.2 percent in comparison to a 21.4 percent recall rate, 79.4 percent specificity and 79.5 percent accuracy for the combination of mammography, ultrasound, and artificial intelligence (AI).
Mammography-Based Deep Learning Model May Help Detect Precancerous Changes in High-Risk Women
July 27th 2023In a dataset enriched for African American women, BRCA mutation carriers and those with benign breast disease, a mammography-based deep learning model demonstrated a five-year AUC of 63 percent for predicting breast cancer in comparison to 54 percent for BI-RADS assessment.
Study: AI Assessment of Chest CT May Predict Multiple Mortality Risks
July 26th 2023In a study of over 20,700 people, researchers found that artificial intelligence (AI) analysis of body composition measurements via lung cancer screening computed tomography (CT) exams improves the prediction of mortality risks for lung cancer, cardiovascular disease, and all-cause mortality.